Greene Barry E
- SEC CIK
- 0001291963
No open-market purchases or sales filed in the past year.
Current role at each company
- DYN Dyne Therapeutics, Inc.Directoras of Jun 23, 2026
- KPTI Karyopharm Therapeutics Inc.Directoras of May 26, 2026
- SAGE Sage Therapeutics, Inc.President and CEOas of Jul 31, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Greene Barry E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SAGE Sage Therapeutics, Inc.
President and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 (view filing) | Nov 10 | 5 days | Greene Barry EPresident and CEO | PPurchase | +14.5K | $34.48 | +$500.0K | +44.7%46.9K after | |
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Greene Barry EPresident and CEO | PPurchase | +23.6K | $43.15 | +$1.02M | +268.6%32.4K after |